Bio-IT World Conference & Expo 2008 Advisory Board

• Samuel (Sandy) Aronson, Executive Director of Information Technology, Harvard Medical School - Partners Healthcare Center for Genetics and Genomics

• Alex Bangs, CTO and co-Founder, Entelos, Inc.

• Sylva Collins, Ph.D., Vice President, Global Biometrics, Kendle

• Kevin Davies, Ph.D., Editor-in-Chief, Bio-IT World　

• Kenneth Getz, M.B.A., Senior Research Fellow, Tufts Center for the Study of Drug Development/Chairman, CISCRP

• Stan Gloss, Managing Director, BioTeam　

• William Hayes, Ph.D., Associate Director, Literature Informatics, Biogen Idec　

• Andrew Hopkins, Ph.D., Chair, University of Dundee

• Phillips Kuhl, Co-Founder and President, Cambridge Healthtech Institute　

• Martin D. Leach, Ph.D., Executive Director Basic Research & Biomarker IT, Merck & Co, Inc.

• Michael Liebman, Ph.D., Executive Director, Windber Research Institute

• Eric Neumann, Ph.D., Clinical Semantics Group Consulting

• Ulrik Nielsen, Ph.D., Vice President, Research, Merrimack Pharmaceuticals

• Rudy Potenzone, Ph.D., WW Industry Technology Strategist for Pharmaceuticals, Microsoft

• James Reaney, Director, Research Markets, Bluearc Corp.　

• James Rogers, CEO, Nextrials

• Don Rule, Technical Program Manager, Health Solutions Group, Microsoft Corporation

• John Russell, Executive Editor, Bio-IT World　

• Jerald S. Schindler, Dr.P.H., Vice President, Biostatistics and Research Decision Sciences, Late Stage Clinical Development Statistics, Merck Research Laboratories　

• Dietrich Stephan, Ph.D., Director and Senior Investigator, Translational Genomics Research Institute

• Susie Stephens, Ph.D., Principal Research Scientist, Eli Lilly

• Jeff Williams, CEO, CLINIPACE, Inc.